Indian pharmaceutical giant Ranbaxy Laboratories Ltd. said Tuesday that it has signed a settlement with the U.S. Food and Drug Administration, committing to bolster its product manufacturing practices.
The company also said it intends to set aside a provision of $500 million to cover any potential criminal and civil liability stemming from an investigation by the U.S. Department of Justice.
Thursday, December 22, 2011
Ranbaxy settles with FDA over manufacturing - Yahoo! Finance
Subscribe to:
Post Comments (Atom)
1 comment:
Post a Comment